Current Cardiovascular Drugs
Details
'This fourth edition of Current Cardiovascular Drugs provides an updated practical compendium of current knowledge regarding cardiovascular drug therapy. It is written in a concise, easily readable format.
This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
Updated practical compendium of current knowledge regarding cardiovascular drug therapy Concise, easily readable format Uses supportive reference material from the most authoritative sources and published clinical trials Organized into chapters by drug class Details the pharmacologic characteristics of specific treatment entities
Inhalt
Alpha-Adrenergic Blockers.- Alpha2-Adrenergic Agonists.- Angiotensin-Converting Enzyme Inhibitors.- Angiotensin II Receptor Blockers.- Antiarrhythmic Agents.- Antithrombotic Therapy.- Beta-Adrenergic Blockers.- Calcium Antagonists.- Diuretics.- Isotropic and asopressor Agents.- Lipid-Lowering Drugs.- Neuronal and Ganglionic Blockers.- Vasodilators.
Weitere Informationen
- Allgemeine Informationen- Sprache Englisch
- Editor William H. Frishman, Angela Cheng- Lai, James Nawarskas
- Titel Current Cardiovascular Drugs
- ISBN 978-1-57340-221-7
- Format Fester Einband
- EAN 9781573402217
- Jahr 2005
- Größe H280mm x B280mm x T216mm
- Gewicht 966g
- Auflage 4th ed. 2005
- Genre Medizin
- Lesemotiv Verstehen
- Anzahl Seiten 384
- Herausgeber Springer-Verlag GmbH
- GTIN 09781573402217
 
 
    
